Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-10 01:36 | 2026-03-05 | GRAL | GRAIL, Inc. | Freidin Aaron | Officer; Chief Financial Officer | Services-Medical Laboratories | SALE | $48.96 | 3,147 | $154,062 | 306,475 | -1.0% |
| 2026-03-04 04:45 | 2026-03-02 | GRAL | GRAIL, Inc. | Freidin Aaron | Officer; Chief Financial Officer | Services-Medical Laboratories | SALE | $50.17 | 9,573 | $480,244 | 309,622 | -3.0% |
| 2025-12-06 00:12 | 2025-12-03 | GRAL | GRAIL, Inc. | Freidin Aaron | Officer; Chief Financial Officer | Services-Medical Laboratories | SALE | $99.15 | 25,000 | $2,478,818 | 259,077 | -8.8% |
| 2025-11-20 00:08 | 2025-11-17 | GRAL | GRAIL, Inc. | Freidin Aaron | Officer; Chief Financial Officer | Services-Medical Laboratories | SALE | $79.20 | 1,697 | $134,402 | 284,077 | -0.6% |
| 2025-08-20 23:23 | 2025-08-19 | GRAL | GRAIL, Inc. | Freidin Aaron | Officer; Chief Financial Officer | Services-Medical Laboratories | SALE | $32.02 | 877 | $28,082 | 285,143 | -0.3% |
| 2025-07-18 00:44 | 2025-07-15 | GRAL | GRAIL, Inc. | Freidin Aaron | Officer; Chief Financial Officer | Services-Medical Laboratories | SALE | $38.93 | 8,000 | $311,440 | 286,020 | -2.7% |
| 2025-05-06 03:46 | 2025-05-02 | GRAL | GRAIL, Inc. | Freidin Aaron | Officer; Chief Financial Officer | Services-Medical Laboratories | SALE | $33.93 | 41,150 | $1,396,220 | 294,020 | -12.3% |
| 2025-04-03 23:45 | 2025-03-11 | GRAL | GRAIL, Inc. | Freidin Aaron | Officer; Chief Financial Officer | Services-Medical Laboratories | SALE | $31.20 | 1,816 | $56,659 | 335,170 | -0.5% |
| 2025-03-12 23:04 | 2025-03-07 | GRAL | GRAIL, Inc. | Freidin Aaron | Officer; Chief Financial Officer | Services-Medical Laboratories | SALE | $31.20 | 1,816 | $56,659 | 335,170 | -0.5% |
| 2025-03-07 00:30 | 2025-03-05 | GRAL | GRAIL, Inc. | Freidin Aaron | Officer; Chief Financial Officer | Services-Medical Laboratories | SALE | $41.51 | 521 | $21,627 | 336,986 | -0.2% |
| 2024-11-20 00:06 | 2024-11-18 | GRAL | GRAIL, Inc. | Freidin Aaron | Officer; Chief Financial Officer | Services-Medical Laboratories | SALE | $14.02 | 30,452 | $426,937 | 268,277 | -10.2% |
| 2024-08-22 23:02 | 2024-08-21 | GRAL | GRAIL, Inc. | Freidin Aaron | Officer; Chief Financial Officer | Services-Medical Laboratories | SALE | $16.25 | 15,641 | $254,121 | 173,429 | -8.3% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.